Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PSTX | BMY | AMGN | GILD | ILMN |
| Company | Poseida Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.00 | 48.21 | 264.63 | 66.25 | 117.69 |
| High | 2.07 | 49.05 | 269.38 | 66.83 | 119.22 |
| Low | 1.95 | 48.12 | 260.68 | 66.16 | 116.61 |
| Last | 2.02 | 48.93 | 268.93 | 66.76 | 117.43 |
| Change | +0.02 | +0.63 | +6.18 | +0.60 | +0.74 |
| % Change | +1.00% | +1.30% | +2.35% | +0.91% | +0.63% |
| Volume | 641,400 | 10,303,900 | 3,380,300 | 10,657,000 | 1,418,200 |
| 20-Day Average Volume | 578,595 | 11,303,500 | 2,246,435 | 6,455,920 | 1,499,510 |
| Previous Close | 2.00 | 48.30 | 262.75 | 66.16 | 116.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.76 | 50.85 | 272.56 | 69.90 | 128.39 |
| 20-Day Raw Stochastic | 10.14% | 19.17% | 29.59% | 10.79% | 6.98% |
| 20-Day Relative Strength | 34.25% | 41.16% | 43.95% | 31.30% | 36.48% |
| Weighted Alpha | -57.12 | -28.90 | +7.67 | -24.32 | -45.51 |
| Today's Opinion | 24% Sell | 72% Sell | 56% Sell | 100% Sell | 72% Sell |
| Previous Opinion | 24% Sell | 72% Sell | 56% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 40% Buy | 24% Sell | 8% Sell | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -26.01% since 04/12/24 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -7.59% since 04/12/24 |
| Low | 1.87 on 04/16/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 2.71 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 128.28 on 04/15/24 |
| 1-Month | |||||
| %Chg | -30.58% since 03/19/24 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -11.81% since 03/19/24 |
| Low | 1.87 on 04/16/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 3.35 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | -26.81% since 01/19/24 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -13.58% since 01/19/24 |
| Low | 1.87 on 04/16/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 4.27 on 03/01/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -14.77% since 10/19/23 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | -2.13% since 10/19/23 |
| Low | 1.83 on 10/30/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 4.27 on 03/01/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 192,978 | 97,892,464 | 140,812,720 | 82,374,304 | 18,583,468 |
| Shares Outstanding, K | 96,489 | 2,026,759 | 535,919 | 1,245,077 | 159,255 |
| Annual Sales | 64,700,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -123,430,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 25,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -25,350,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 0.36 | 0.39 | 0.58 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 03/07/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 135.97 |